Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

PHASE3CompletedINTERVENTIONAL
Enrollment

1,607

Participants

Timeline

Start Date

September 29, 2015

Primary Completion Date

June 25, 2018

Study Completion Date

June 25, 2018

Conditions
Rhinitis, Allergic, PerennialHouse Dust Mite Allergy
Interventions
BIOLOGICAL

300 IR

300 IR tablet of HDM Allergen Extracts

BIOLOGICAL

Placebo

Placebo tablet

Trial Locations (2)

33610

University of South of Florida, Tampa

34295

CHU Arnaud de Villeneuve, Montpellier

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Stallergenes Greer

INDUSTRY

NCT02443805 - Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR | Biotech Hunter | Biotech Hunter